Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is licensed for subcutaneous injection into three areas: the abdomen, the upper thigh, or the upper arm. Each site delivers the medicine under the skin, but your choice of injection area affects comfort, absorption consistency, and how easily you can self-administer. These are prescription-only medicines; a GPhC-registered prescriber decides whether treatment is clinically appropriate for you, and your Patient Information Leaflet is the definitive guide to technique. What follows is an accurate, practical overview of the areas to inject Mounjaro and the factors that help you pick between them.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The area around the abdomen is the most commonly chosen site, and for good reason. There is usually enough subcutaneous fat to make the injection straightforward, and you have a clear view of what you are doing. Inject at least 5 cm away from the navel to avoid the firmer tissue directly around it. The tolerable zone runs across the lower and lateral abdomen in a band roughly from your hip bones to just below your ribs on each side.
One thing our prescribers hear fairly often: people who are self-conscious about the abdomen site sometimes avoid it and end up using the same spot on their thigh week after week. That pattern leads to skin changes and less predictable absorption. If the abdomen feels awkward at first, it tends to become routine within a couple of doses.
Learn more about day-to-day injection considerations in our overview of how Mounjaro injections work. And because fresh needles reduce injection-site trauma, it is worth having a reliable supply, compatible needle packs are available from our pharmacy if needed.
The front and outer upper thigh is the second most popular area. Sit down, rest your leg flat, and the tissue is easy to pinch and see. Aim for the middle third of the thigh, roughly halfway between knee and hip, on the front or outer surface. Avoid the inner thigh, where the skin is thinner and more sensitive.
Absorption from the thigh is broadly similar to the abdomen in clinical practice, though individual variation exists. What matters more than the precise site is that you rotate consistently. The NHS tirzepatide patient page notes that injection-site reactions are among the more common local effects; rotation is the main way to keep them mild.
If you want to compare how the thigh stacks up against other sites based on research, our page on the best area to inject Mounjaro covers the evidence in more detail.
The outer, fleshy part of the upper arm is a licensed site, but self-injection there is genuinely difficult. Reaching around to pinch the skin, position the pen correctly, and press the button without wobbling takes practice most people never fully master alone. If a partner or family member can assist, the arm becomes a useful option that gives the abdomen and thigh a longer rest between rotations.
Three sites, rotated in sequence, means each individual spot gets roughly three weeks to recover before it sees a needle again. That gap is meaningful for skin health. Full technique guidance, including how the KwikPen mechanism works, is in our dedicated Mounjaro arm injection guide.
For a broader look at tirzepatide injection technique across all three sites, the tirzepatide injection areas page covers the clinical detail.
Clean the chosen spot with an alcohol swab and let it dry for a few seconds before injecting, wet skin stings more and can dilute the surface disinfection. Pre-saturated swabs make this step quick. After the injection, press gently with a cotton pad; do not rub, which can disperse the medicine unevenly into surrounding tissue.
Keeping a simple note of where you injected each week (even a brief phone photo of the spot) removes the guesswork when you reach for the next pen. Some people use a rotation chart printed from the manufacturer; others just mentally cycle between the three areas. Either approach works. What does not work is defaulting to the same convenient patch of skin because it felt fine last time.
Sharps disposal matters too. Each pen, after use, should go directly into a sealed sharps container for safe disposal through your local authority's collection scheme, never into household rubbish.
If you are new to Mounjaro and still deciding whether it is the right route for you, our introduction to Mounjaro injections explains the broader context, including how the medicine works and who it is licensed for. For a full picture of treatment costs, see our Mounjaro cost page, which sets out what private treatment typically includes.
If you are ready to explore whether tirzepatide treatment is clinically suitable for you, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.